Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362432700> ?p ?o ?g. }
Showing items 1 to 66 of
66
with 100 items per page.
- W4362432700 abstract "<p>Supplementary methods and Figures S1-S7. Supplementary Methods. Detailed description of reagents and protocols used for immunohistochemical and metastasis analysis, and immunofluorescence microscopy analysis. Supplementary Figure S1. Histopathological staging of insulinoma development in Rip1Tag2 transgenic mice (A); quantification of tumor cell apoptosis (B) and tumor cell proliferation (C) in nintedanib and vehicle-treated Rip1Tag2 mice; determination of the IC50 of nintedanib in repressing cultured insulinoma cells (D). Supplementary Figure S2. Quantification of the number of NG2-positive pericytes (A) and the percentage of perivascular cells not associated with blood vessels (B) in tumors of nintedanib and vehicle-treated Rip1Tag2 mice. Supplementary Figure S3. Quantification and localization of hypoxic areas in tumors of nintedanib and vehicle-treated Rip1Tag2 mice (A-D). Supplementary Figure S4. Quantification of microvessel density (A), tumor volumes (B) and tumor grading (C) in tumors of nintedanib, PTK/ZK, sunitinib and vehicle-treated Rip1Tag2 mice. Supplementary Figure S5. Quantification of liver metastasis in mice treated open-end with nintedanib. Supplementary Figure S6. Quantification of microvessel density (A, C) and tumor volumes (B, D) of tumors from Rip1Tag2 mice treated for 5 days with nintedanib (A, B) or for 3 weeks with sunitinib (C, D). Supplementary Figure S7. Quantification of microvessel density (A, C) and volumes (B, D) of tumors from Rip1Tag2 mice treated with PTK/ZK following the onset of tumorigenesis for 3, 4, 5, and 6 weeks (A, B) or for 5 days at a later stage of tumor development (C, D).</p>" @default.
- W4362432700 created "2023-04-05" @default.
- W4362432700 creator A5000691299 @default.
- W4362432700 creator A5032291555 @default.
- W4362432700 creator A5048615168 @default.
- W4362432700 creator A5056019571 @default.
- W4362432700 creator A5071554416 @default.
- W4362432700 creator A5072271891 @default.
- W4362432700 creator A5074720413 @default.
- W4362432700 creator A5082016235 @default.
- W4362432700 creator A5088604141 @default.
- W4362432700 date "2023-03-31" @default.
- W4362432700 modified "2023-09-29" @default.
- W4362432700 title "Supplementary methods and Figures S1-S7 from Nintedanib Is a Highly Effective Therapeutic for Neuroendocrine Carcinoma of the Pancreas (PNET) in the Rip1Tag2 Transgenic Mouse Model" @default.
- W4362432700 doi "https://doi.org/10.1158/1078-0432.22458375" @default.
- W4362432700 hasPublicationYear "2023" @default.
- W4362432700 type Work @default.
- W4362432700 citedByCount "0" @default.
- W4362432700 crossrefType "posted-content" @default.
- W4362432700 hasAuthorship W4362432700A5000691299 @default.
- W4362432700 hasAuthorship W4362432700A5032291555 @default.
- W4362432700 hasAuthorship W4362432700A5048615168 @default.
- W4362432700 hasAuthorship W4362432700A5056019571 @default.
- W4362432700 hasAuthorship W4362432700A5071554416 @default.
- W4362432700 hasAuthorship W4362432700A5072271891 @default.
- W4362432700 hasAuthorship W4362432700A5074720413 @default.
- W4362432700 hasAuthorship W4362432700A5082016235 @default.
- W4362432700 hasAuthorship W4362432700A5088604141 @default.
- W4362432700 hasBestOaLocation W43624327001 @default.
- W4362432700 hasConcept C126322002 @default.
- W4362432700 hasConcept C142724271 @default.
- W4362432700 hasConcept C2777472916 @default.
- W4362432700 hasConcept C2777714996 @default.
- W4362432700 hasConcept C2778341716 @default.
- W4362432700 hasConcept C2779066768 @default.
- W4362432700 hasConcept C2779490328 @default.
- W4362432700 hasConcept C2780171596 @default.
- W4362432700 hasConcept C502942594 @default.
- W4362432700 hasConcept C71924100 @default.
- W4362432700 hasConceptScore W4362432700C126322002 @default.
- W4362432700 hasConceptScore W4362432700C142724271 @default.
- W4362432700 hasConceptScore W4362432700C2777472916 @default.
- W4362432700 hasConceptScore W4362432700C2777714996 @default.
- W4362432700 hasConceptScore W4362432700C2778341716 @default.
- W4362432700 hasConceptScore W4362432700C2779066768 @default.
- W4362432700 hasConceptScore W4362432700C2779490328 @default.
- W4362432700 hasConceptScore W4362432700C2780171596 @default.
- W4362432700 hasConceptScore W4362432700C502942594 @default.
- W4362432700 hasConceptScore W4362432700C71924100 @default.
- W4362432700 hasLocation W43624327001 @default.
- W4362432700 hasLocation W43624327002 @default.
- W4362432700 hasOpenAccess W4362432700 @default.
- W4362432700 hasPrimaryLocation W43624327001 @default.
- W4362432700 hasRelatedWork W1921137702 @default.
- W4362432700 hasRelatedWork W2015593382 @default.
- W4362432700 hasRelatedWork W2041388319 @default.
- W4362432700 hasRelatedWork W2058491998 @default.
- W4362432700 hasRelatedWork W2071901162 @default.
- W4362432700 hasRelatedWork W2205117195 @default.
- W4362432700 hasRelatedWork W2276963782 @default.
- W4362432700 hasRelatedWork W2803478679 @default.
- W4362432700 hasRelatedWork W4220669495 @default.
- W4362432700 hasRelatedWork W4362432700 @default.
- W4362432700 isParatext "false" @default.
- W4362432700 isRetracted "false" @default.
- W4362432700 workType "article" @default.